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Abstract
Human spermatozoa generate low levels of reactive oxygen species in order to stimulate key
events, such as tyrosine phosphorylation, associated with sperm capacitation. However, if the
generation of these potentially pernicious oxygen metabolites becomes elevated for any reason,
spermatozoa possess a limited capacity to protect themselves from oxidative stress. As a
consequence, exposure of human spermatozoa to intrinsically- or extrinsically- generated reactive
oxygen intermediates can result in a state of oxidative stress characterized by peroxidative damage
to the sperm plasma membrane and DNA damage to the mitochondrial and nuclear genomes.
Oxidative stress in the male germ line is associated with poor fertilization rates, impaired
embryonic development, high levels of abortion and increased morbidity in the offspring, including
childhood cancer. In this review, we consider the possible origins of oxidative damage to human
spermatozoa and reflect on the important contribution such stress might make to the origins of
genetic disease in our species.
1. Introduction – origins of genetic disease
The maintenance of genetic integrity in the male germ line
has major repercussions for conception, the progress of
pregnancy and, ultimately, the health and well-being of
the progeny [1]. The human male contributes heavily to
germ line mutations [2], and as such, is responsible for
most of the dominant genetic diseases observed in our
species. Indeed, in some cases, such as multiple endocrine
neoplasia or achondroplasia (short-limbed dwarfism),
the phenotype is invariably the result of mutations that
can be traced back to the paternal germ line [2]. Epidemi-
ological data also suggest that paternally derived genetic
damage may contribute significantly to the aetiology of
cancer in children and young adults [1,2].
These observations raise important questions about the
aetiology of genetic damage in the male germ line and the
causal links that exist between the induction of such dam-
age and the inheritance of many childhood diseases. As
early as 1912, Wilhelm Weinberg (cited in [2]) reported
that children with dominant achondroplasia born to nor-
mal parents were among the last-born children in the fam-
ily. Later work by Penrose [3] suggested that the effect
observed by Weinberg was not actually correlated with
birth order, nor surprisingly, maternal age. Rather, achon-
droplasia was a disease associated with paternal age. The
implications of these findings were vast. Why is it that a
much greater mutation rate apparently exists in the male
germ line compared to the female? And why are several X-
linked recessive and autosomal-dominant diseases corre-
lated with paternal age?
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probable cause of such mutations as a consequence of the
higher number of cell divisions involved in generating a
spermatozoon (approximately 840 for a 50 year old male)
as opposed to an ovulated egg (approximately 22 divi-
sions regardless of age). If this is the case, then the muta-
tions would have to be generated and retained in
mitotically active spermatogonia. In the case of Apert syn-
drome, for example, there is good reason to believe that
the causative mutation (in this case, predominantly a
755C-G transversion in the FGFR-2 gene) arises in sper-
matogonia and is selectively retained in the germinal epi-
thelium because the mutant germ cells enjoy an
unspecified selective advantage [4].
However, the replication-error hypothesis does not hold
for all dominant genetic mutations; achondroplasia being
a particular case-in-point. By taking sperm DNA from
donors of different ages, Tiemann-Boege and colleagues
[5] have examined the frequency of nucleotide substitu-
tions in the fibroblast growth factor receptor 3 (FGFR3)
gene that are the predominant cause this condition. They
concluded that the magnitude of the increased mutation
frequency associated with paternal age was insufficient to
explain the exponential rise in the incidence of achondro-
plasia in the offspring [4]. Of the several possible hypoth-
eses that have been advanced to explain this situation, one
of the most plausible proposes that replication error is not
responsible for the mutations causing for this disease.
Rather, age-related premutational lesions may have
occurred in these cells that are converted to the authentic
mutation (most commonly a glycine to arginine substitu-
tion at codon 1,138) following fertilization, as a conse-
quence of aberrant DNA repair in the zygote [5,6].
In order for the premutational lesion hypothesis to
account for a mutation that is present in every cell of the
body, rather than a mosaic, this putative aberrant repair
would have to precede the S phase of the first mitotic divi-
sion. The oocyte is well endowed with poorly character-
ized enzymes for effecting DNA repair [7,8], including
enzymes that are known to be active prior to the initiation
of DNA synthesis during S-phase, at a time when the
sperm chromatin is undergoing decondensation [9]. If an
oocyte is fertilized with DNA-damaged spermatozoa,
these G1-associated DNA repair mechanisms become acti-
vated, leading to a dramatic suppression of pronuclear
DNA-synthesis via a p53 -dependent mechanism [9].
Of course, aberrant repair of DNA damage in the oocyte
could account for a wide variety of genetic aberrations in
embryos generated from DNA damaged spermatozoa, not
just point mutations. Thus, exposure of spermatozoa to
xenobiotics or X-irradiation is known to induce dominant
lethal effects (post implantation pregnancy loss) and her-
itable translocations in the embryos of mated females as a
consequence of chromosome mutations (breaks and rear-
rangements) as well as specific locus mutations [10,11]
that could be the result of aberrant repair in the oocyte. If
this mechanism is of fundamental importance in the cau-
sation of genetic disease, it places emphasis on discover-
ing both the nature and extent of DNA damage in
spermatozoa and the fidelity of the repair processes acti-
vated in the oocyte. Interestingly, there appear to be pro-
found genetic differences in the capacity of oocytes to
repair DNA damage introduced by the fertilizing sperma-
tozoon [12]. However, what could be causing the DNA
damage in spermatozoa? A possible clue might be found
in the type of mutation most commonly observed in cases
of achondroplasia.
As indicated above, the mutation seen in a vast majority
of achondroplasia patients is a CG-AT transition in the
FGFR3 gene. Since this is the most common base substitu-
tion observed following oxidative damage to DNA
[13,14], it is plausible that the lesions responsible for the
initiation of aberrant DNA repair in the oocyte are oxida-
tive in nature. Such a hypothesis is in keeping with an
extensive literature indicating that the functional lesions
observed in the spermatozoa of infertile men, are com-
monly associated with signs of oxidative stress [1].
ROS generation in spermatozoa
Oxidative stress, and its role in the origins of male infertil-
ity was first appreciated in 1943, when the Scottish
andrologist John MacLeod demonstrated that catalase
could support the motility of human spermatozoa incu-
bated under aerobic conditions [15]. His explanation for
these findings, that human spermatozoa are vulnerable to
oxidative stress created by reactive oxygen species (ROS)
such as H2O2, has been confirmed in a number of inde-
pendent studies [1]. Human spermatozoa are capable of
generating ROS and this activity is of physiological signif-
icance in promoting the tyrosine phosphorylation events
associated with sperm capacitation. The ability of ROS to
enhance the tyrosine phosphorylation status of human
spermatozoa depends partly on the ability of H2O2 to sup-
press tyrosine phosphatase activity, and partly on the abil-
ity of these molecules to stimulate cAMP generation by
the soluble form of adenylyl cyclase (sAC) [16,17]. The
cAMP generated in this manner then stimulates tyrosine
phosphorylation via a PKA dependent mechanism involv-
ing an, as yet, uncharacterised intermediary tyrosine
kinase [17]. Redox control of tyrosine phosphorylation
during sperm capacitation has been recorded for a large
number of species including the rat [18], mouse [19],
human [17], bull [16] and stallion [20].
This redox drive to capacitation involves a low, steady
state level of ROS production. However, if, for any reason,Page 2 of 9
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or the spermatozoa should become exposed to exogenous
ROS generated by, for example, infiltrating leukocytes,
then a state of oxidative stress can be readily induced.
Spermatozoa are particularly susceptible to such stress as
a consequence of their high unsaturated fatty acid content
and their limited store of antioxidant enzymes such as
superoxide dismutase or glutathione peroxidase [1]. In
keeping with this concept, exposure of human spermato-
zoa to ROS generated by xanthine oxidase disrupts the
functional competence of spermatozoa at levels that have
little impact on somatic cells and, importantly, this effect
can be reversed by the addition of catalase [21,22]. Of
interest in the context of this review, is that this same sys-
tem has been used to demonstrate the damaging effect of
ROS on nuclear DNA in spermatozoa [23]. Direct expo-
sure of human spermatozoa to ROS disrupts not only the
functional competence of these cells but also their
genomic integrity [24]. In relation to the paternal origins
of disease, it is significant that endogenous ROS generated
by human spermatozoa can, and does, affect sperm func-
tion and DNA integrity [6]. The current debate centers on
how such oxidative stress is created.
Monitoring ROS production by spermatozoa
Following the initial report from Macleod [15], Aitken
and Clarkson [25] went on to interpret the high levels of
luminol-dependent chemiluminescence they observed in
the spermatozoa of infertile patients, as evidence for ROS
generation by such cells. The subpopulations of human
spermatozoa responsible for this luminol-dependent
activity have subsequently been isolated in the low den-
sity region of Percoll gradients [26,27] and linkages estab-
lished with the aberrant retention of excess residual
cytoplasm during spermiogenesis [27,28].
To further understand the biochemical basis of ROS gen-
eration in spermatozoa, attention soon focused on the use
of other ROS-detecting probes apart from luminol. Owing
to its sensitive nature, a popular reagent to use in this con-
text was lucigenin. Lucigenin has been frequently
deployed for the detection of ROS and is certainly capable
of detecting superoxide anion (O2-•) [29,30]. For exam-
ple, this probe has been used to detect NADPH oxidase
type 2 (NOX2) -dependent O2-• production in phagocytic
cells and in cell-free ROS-generating systems, such as xan-
thine plus xanthine oxidase [31]. In the context of sper-
matozoa, lucigenin as been used successfully to detect the
generation of O2-• in rat sperm suspensions isolated from
the cauda epididymides [32]. This signal was shown to be
of mitochondrial origin, being inhibited by rotenone and
stimulated by lactate, succinate and malate [32]. Although
this is very good evidence for the production of mitochon-
drial ROS generation by rat spermatozoa, it is uncertain as
to whether mitochondria are an important source of ROS
in the spermatozoa of other species, particularly the
human [25].
Notwithstanding the fact that mitochondrial production
of ROS in spermatozoa remains largely unexplored, Ver-
Schematic representation of NAD(P)H oxidase activityFigure 1
Schematic representation of NAD(P)H oxidase activity. This enzymes transfers electrons from NAD(P)H to ground state oxy-
gen to create the superoxide anion radical. The latter then dismutates to hydrogen peroxide under the influence of superoxide 
dismutase. The hydrogen peroxide is predominantly scavenged by glutathione peroxidase, since human spermatozoa possess 
little catalase activity. Once this peroxidase activity is overwhelmed, a state of oxidative stress may be induced that disrupts the 
fertilizing capacity of the spermatozoa and the integrity of their DNA.Page 3 of 9
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mitochondrial production of ROS by rat spermatozoa. By
isolating rat sperm membranes and adding lucigenin
together with NADPH as a co-factor, they were able to
show definitive chemiluminescent signals in this model
system. This signal was inhibited with superoxide dis-
mutase (SOD), DPI (diphenylene iodonium) and zinc
[32]. Furthermore, addition of NADPH together with luci-
genin to suspensions of human [33], mouse [34] rat [32]
wallaby [35] and stallion [36] spermatozoa demonstrated
that this lucigenin-dependent redox activity is a ubiqui-
tous feature of mammalian spermatozoa.
In the case of human spermatozoa, NADPH-dependent
lucigenin chemiluminescence was of non-mitochondrial
in origin, being insensitive to rotenone, antimycin A, car-
bonyl cyanide m-chlorophenylhydrazone and sodium
azide [33]. The initial interpretation of these data was that
they represented support for the presence of an NADPH-
oxidase in spermatozoa that could be responsible for the
high rates of NAD(P)H-induced, lucigenin-dependent
chemiluminescence recorded in defective sperm popula-
tions [37]. The general concept of such a theoretical oxi-
dase is presented in Fig. 1. In essence, the enzyme serves
to transfer electrons from NAD(P)H to ground state oxy-
gen to create O2-• that then dismutates to H2O2 under the
influence of intracellular superoxide dismutase (Fig. 1).
The interpretation of these NADPH-induced, lucigenin-
dependent chemiluminescence signals is complex how-
ever [38], because of the tendency of this probe to redox
cycle as a result of one-electron reductions conducted by
enzymes, such as cytochrome-P450 reductase [39]. This
scheme proposes the following steps: (i) a one electron
reduction of lucigenin (L) under the influence of cyto-
chrome P450-reductase and NADPH to generate a radical
species (LH+•), (ii) a reaction between the latter and
Schematic representation of the underlying chemistry of lucigenin chemiluminescenceFigure 2
Schematic representation of the underlying chemistry of lucigenin chemiluminescence. Luc2+ = lucigenin; LH+• = a lucigenin rad-
ical created by the one electron reduction of Luc2+. The reaction of LH+• with oxygen generates O2-•. The latter then partici-
pates in an oxygenation reaction with LH+• generating a dioxetane that decomposes with the generation of chemiluminescence. 
Any entity that can bring about the one electron reduction of lucigenin can potentially create a redox cycle in the presence of 
oxygen that produces high levels of O2-• and chemiluminescence. It is impossible to distinguish the relative contribution of such 
probe-dependent and cell-dependent chemiluminescence. Hence data obtained with this probe should be interpreted with cau-
tion.Page 4 of 9
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genin back to its native state (L), (iii) and finally a reaction
between LH+• and O2-•, generated as a result of the redox
cycling of lucigenin, to produce a dioxetane that, in turn,
decomposes with the generation of chemiluminescence
(Fig. 2).
As a consequence of this chemistry, O2-•-dependent, SOD-
sensitive chemiluminescence can be generated in cellular
systems that do not generate ROS themselves but are sim-
ply capable of redox-cycling the probe (lucigenin) used to
detect this activity. In a similar fashion, NADH-induced
lucigenin-dependent chemiluminescence has been shown
to be associated with another intracellular reductase, cyto-
chrome b5-reductase (CYB5R) in spermatozoa [40]. Thus,
CYB5R was shown to co-elute from an anion exchange
column with NADH-induced, lucigenin-dependent
chemiluminescence activity, while over-expression of this
same enzyme led to a 3-fold increase of this activity in
COS7 cells. Although CYB5R is capable of reducing luci-
genin in the presence of NADH, a paradox has arisen from
these studies in that CYB5R should be inhibited by DPI.
However, the NADH-dependent enzyme responsible for
lucigenin reduction in spermatozoa is not inhibited with
this reagent. Two explanations for this discrepancy are
worthy of consideration. First, it is plausible that DPI pen-
etration to the sites of lucigenin action may be limited in
intact cells (this would explain why DPI was so much
more effective in suppressing the lucigenin chemilumi-
nescence observed in cell-free partially purified CYB5R
preparations, compared with transiently transfected intact
cells [35]) or alternatively, a second DPI-insensitive
enzyme system may exist in whole cells, that is also capa-
ble of activating lucigenin.
Although this general redox cycling concept (Fig. 2) seems
to explain how SOD-inhibited NAD(P)H-dependent
chemiluminescence can be generated in the absence of
primary O2-• production, it has also been argued that the
reaction between LH+• and O2 is thermodynamically
unlikely [41] and that redox cycling of this probe cannot
occur in biological systems. In light of such reservations,
we cannot be certain of the extent to which the elevated
NAD(P)H-induced lucigenin signals detected in defective
human spermatozoa [37] reflect primary O2-• production.
NAD(P)H-induced chemiluminescence and oxidative stress
Even if NAD(P)H-induced lucigenin-dependent chemilu-
minescence does simply reflect the presence of oxidore-
ductases capable of initiating the redox cycling of the
probe, rather than primary O2-• generation, the diagnostic
significance of this activity may still reside in its ability to
reflect oxidative stress in human sperm populations
[37,42,43]. Thus, if the inter-individual differences in
lucigenin chemiluminescence reflect the varying availabil-
ity of certain reductases, this must, in turn, reflect inter-
individual differences in the retention of residual cyto-
plasm during spermiogenesis. Such a conclusion would
be in keeping with a large number of studies indicating
that defective sperm function is positively correlated with
the presence of numerous cytosolic enzymes that are
markers of the cytoplasmic space, including lactic acid
dehydrogenase, creatine kinase, SOD and glucose-6-phos-
phate dehydrogenase [6]. These observations, in turn,
Errors during spermiogenesis can lead to the retention of exces residual cytoplasm by human spermatozoaFigure 3
Errors during spermiogenesis can lead to the retention of 
excess residual cytoplasm by human spermatozoa. A) arrows 
point to cells possessing an irregular cytoplasmic mass in the 
neck region of the spermatozoon; significantly, human sper-
matozoa have lost the ability, possessed by most other mam-
malian species, to create a cytoplasmic droplet which is later 
discharged from the cell B) The amount of cytoplasm 
retained by human spermatozoa is highly correlated with the 
ability of leukocyte-free sperm suspensions to generate a 
chemiluminescence response to 12-myristate, 13-acetate 
phorbol ester (PMA), using luminol-peroxidase as the detec-
tion system.Page 5 of 9
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associated with the retention of excess residual cytoplasm
as a result of impaired cytoplasmic extrusion during sper-
miogenesis. Human spermatozoa are unusual in that they
have lost the ability shown by most mammalian species to
remodel any residual cytoplasm into a cytoplasmic drop-
let that is ultimately discharged from the cells either dur-
ing epididymal maturation or at ejaculation. As a
consequence, any residual cytoplasm that remains after
spermiogenesis has been completed in the human, is
retained by the spermatozoa as an amorphous cytoplas-
mic mass in the neck region of the cell (Fig. 3). Retention
of this excess cytoplasm has been associated with the exist-
ence of oxidative stress in the germ line in several inde-
pendent studies [27,28].
An explanation for this association between excess cyto-
plasmic retention and ROS production has been put for-
ward, based on the correlation between the latter and the
cellular content of glucose-6-phosphoate dehydrogenase
in human sperm suspensions [28]. This enzyme regulates
the rate of glucose flux through the hexose monophos-
phate shunt and is, in this way, responsible for controlling
the intracellular availability of NADPH (Fig. 1). The latter
may then serve as a substrate for putative ROS-generating
enzymes in the germ line such as NOX 5 [44], and
thereby, elicit a state of oxidative stress.
Although this explanation is consistent with the data gen-
erated in numerous independent studies, it still has the
status of an unproven hypothesis rather than an experi-
mentally proven fact. Definitive evidence for the presence
of NOX 5 in human spermatozoa has still not been
obtained and we still await independent confirmation of
the ability of NOX 5 to generate ROS in spermatozoa. It
has even been questioned whether human spermatozoa
produce ROS from any source. Using the ability of dihy-
droethidium to react with O2-• and produce 2OH ethid-
ium we have recently secured incontrovertible evidence
that human spermatozoa do in fact generate this free rad-
ical species and that the cellular production of O2-• is sig-
nificantly elevated in populations of defective sperm
populations. Furthermore, the data we have generated to
date suggests that this is not a consequence of defective
mitochondrial function since a variety of mitochondrial
inhibitors fail to disrupt the 2OH ethidium signal.
Such results suggest there must be a source of O2-• in
human spermatozoa that is extra-mitochondrial. A
number of possibilities exist in this context. First of all, the
above-mentioned NADPH-oxidase, NOX5, originally
identified by Banfi et al. in human testes [44,45], has the
potential to generate free radicals in a calcium-dependent
manner, as originally described by Aitken and Clarkson
[25]. Although the presence of NOX5 in human sperma-
tozoa has not yet been confirmed, a recent publication in
the mouse [46] employed Western blot analysis to record
the presence of proteins exhibiting cross reactivity with
antibodies against various components of the leukocyte
NADPH oxidase complex (NOX2) including gp91phox,
p67(phox), p47 phox and p40 (phox). The authors claim
that this unusual oxidase is regulated by the availability of
p40 (phox) and is independent of p22 (phox). They also
assert that this oxidase is maximally active in testicular
spermatozoa but decreases in concert with sperm matura-
tion. Confirmation of this pattern of NADPH oxidase
activity is strategically important since it would add
weight to the argument that ROS production by human
spermatozoa is an inverse function of their state of func-
tional maturity.
In addition to NADPH oxidase activity, it is also clear that
spermatozoa will generate ROS when placed in contact
with certain xenobiotics. Examples of such compounds
include endocrine disruptors with estrogenic properties
that are capable of inducing ROS production by male
germ cells and initiating free radical-mediated DNA dam-
age [47]. Similarly, oxidative stress and DNA damage can
be induced in spermatozoa via metal-catalysed redox
activity involving, for example nickel [48] or iron [49] as
well as phthalate esters [50].
Another potential source of ROS in human spermatozoa
is a trans-plasma membrane oxidoreductase system that
removes electrons from NAD(P)H on the cytoplasmic sur-
face of the cell and transfers them to oxygen on the outer
leaf of the plasma membrane via intermediate carriers
such as ubiquinone. Evidence to support the existence of
such systems in somatic cells, arises from the ability of the
latter to reduce artificial membrane-impermeant electron
acceptors such as potassium ferricyanide, in concert with
the concomitant oxidation of cytosolic NADH [51]. Inter-
estingly, the activity of such plasma membrane oxidase
systems has been demonstrated to increase in Rho O cells
that lack functional mitochondria [51,52]. In such cases,
up-regulation of the plasma membrane redox system may
help maintain an adequate pool of NAD+ to fuel the
increased glycolysis needed to maintain cell viability in
the absence of mitochondrial activity. Human spermato-
zoa have been shown to possess redox activity typical of
such plasma membrane electron transport chains [32,53].
Thus, human spermatozoa possess a capacity to reduce
the probe WST-1 in the presence of an intermediate elec-
tron acceptor in a similar fashion to the plasma mem-
brane redox system described in somatic cells by Berridge
and Tan [54,55]. This transmembrane electron transfer
system in spermatozoa shares similarities with the Ber-
ridge and Tan activity in being inhibited by SOD, capsai-
cin, (a potent vanilloid inhibitor) and N-ethyl maleimide
(NEM, a membrane permeant alkylating agent). However,Page 6 of 9
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membrane impermeant thiol blocking agent pCMBS (p-
chloromercuriphenylsulphonate) as well as retinoic acid,
distinguishes the sperm-based activity from that detected
in somatic cells [37]. Since mitochondrial function is fre-
quently defective in populations of human spermatozoa
[56], it is possible that this trans-plasma membrane redox
system is up-regulated in defective human spermatozoa in
a similar fashion to the enhanced activity recorded in Rho
O cells in order to maintain the redox status of the NAD+/
NADH couple. Further characterization of this putative
electron transport chain is clearly warranted. However,
this task will not be easy given that, by definition, the
redox activity ascribed to such systems depends on the
close interaction of several independent constituents, not
on a single identifiable entity.
Another form of oxidase activity detected by Berridge and
Tan [54,55] is a superficial enzyme that removes electrons
from exogenously applied sources of reducing equivalents
(eg. NAD(P)H) to generate O2-•. Exogenous NAD(P)H
will certainly reduce extracellular electron acceptors such
as WST-1 in the presence of human spermatozoa [37].
Moreover, the susceptibility of such activity to inhibition
with pCMBS corresponds to the activity detected in a vari-
ety of cell types, including HeLa and Jurkat cells, by Ber-
ridge and Tan [54,55]. However, the activity elicited in the
presence of spermatozoa could be distinguished from that
generated by somatic cells by virtue of the lack of stimula-
tion observed with NEM [37,54,55].
Nitric oxide (NO) is another oxygen free radical which is
apparently generated by defective populations of human
spermatozoa. NO is normally generated from L-arginine
by three isoforms of nitric oxide synthase (NOS). Recent
mouse knock out experiments indicate that the selective
deletion of these NOS isoforms has no impact on the abil-
ity of the spermatozoa to achieve fertilization. In other
words, NO does not appear to have a positive role to play
in the generation of functional gametes [57]. However the
fact that iNOS deficient spermatozoa exhibited signifi-
cantly higher in vitro fertilization rates than the wild-type
controls, clearly suggests that NO may be involved in the
etiology of defective sperm function. NO clearly has a det-
rimental effect on normal sperm function inhibiting both
motility and the competence of these cells for sperm-zona
binding [58]. Moreover the NO levels in seminal plasma
are negatively correlated with sperm movement in human
semen samples [59]. The source of this NO is still an open
question. The involvement of NOS is suggested by the
negative correlation observed between the pattern of NOS
expression on human spermatozoa and percentage motil-
ity [60]. However, it has also been pointed out the NO
and peroxynitrite formation can be stimulated in mam-
malian spermatozoa using D-arginine, which cannot be a
substrate for NOS. Under these circumstances it is possi-
ble that NO is being generated non-enzymatically
through an H2O2-mediated attack on arginine [61].
Clearly there are many potential sources of ROS in the
male germ line. The task that now confronts us is to deter-
mine which of these multifarious sources are responsible
for the oxidative stress observed in the spermatozoa of
male patients.
Conclusion
Human spermatozoa are redox active cells that are capa-
ble of generating O2-• and H2O2. This activity is of funda-
mental biological importance in regulating the signal
transduction pathways that control sperm capacitation.
However, excess exposure to ROS can lead to pathological
damage to human spermatozoa curtailing their compe-
tence for fertilization and disrupting their genetic integ-
rity. DNA damage in these cells appears to be largely
oxidative and is associated with a wide variety of adverse
outcomes including impaired conception rates, increased
incidences of abortion and defects in the offspring,
including childhood cancer and dominant genetic dis-
eases such as achondroplasia. It is hypothesized that such
effects in the F1 generation involve the aberrant repair of
oxidative DNA damage in the newly fertilized zygote. The
etiology of oxidative stress in the male germ line is being
actively researched at the present time. While spermato-
zoa certainly generate ROS, the biochemical basis of this
activity is uncertain and may be multifactorial. Errors of
spermiogenesis associated with the retention of excess
residual cytoplasm appear to be associated with oxidative
stress as a consequence of enhanced ROS production by
uncharacterised 'oxidases', plasma membrane electron
transport chains or oxidoreductases capable of activating
redox-cycling xenobiotics. Electron leakage from defective
sperm mitochondria represent yet another potential
source of oxygen radicals. Given the clinical significance
of oxidative stress in human spermatozoa, resolving the
biochemical basis of this condition is a high priority task
for the future.
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